Skip to content

Clinical trials

Phase 3 Waldenstrom Macroglobulinemia trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 3 Status: Unknown status Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clatterbridge Centre for Oncology1
Lymphoma Study Association1
The University of Hong Kong1
University of Glasgow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Follicular4
Lymphoma, Mantle-Cell4
Waldenstrom Macroglobulinemia4
Burkitt Lymphoma3
Hodgkin Disease3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Large-Cell, Immunoblastic3
Lymphoma, Non-Hodgkin3

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.